BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3117447)

  • 61. Plasma growth hormone response to human growth hormone releasing factor in rats administered with chlorpromazine and antiserum against somatostatin. Effects of hypo- and hyperthyroidism.
    Wakabayashi I; Tonegawa Y; Ihara T; Hattori M; Shibasaki T; Ling N
    Neuroendocrinology; 1985 Oct; 41(4):306-11. PubMed ID: 2864652
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth hormone secretion during pregnancy: altered effects of growth hormone releasing factor and insulin-like growth factor-I in vitro.
    Sheppard MS; Bala RM
    Horm Res; 1987; 27(4):205-10. PubMed ID: 2893766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
    Kraicer J; Cowan JS; Sheppard MS; Lussier B; Moor BC
    Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects.
    Valcavi R; Dieguez C; Azzarito C; Edwards CA; Dotti C; Page MD; Portioli I; Scanlon MF
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):453-8. PubMed ID: 3115632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects.
    Sharp PS; Foley K; Chahal P; Kohner EM
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):497-501. PubMed ID: 6424979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Somatotropic, lactotropic and adrenocortical responses to insulin-induced hypoglycemia in patients with rheumatoid arthritis.
    Rovensky J; Bakosová J; Koska J; Ksinantová L; Jezová D; Vigas M
    Ann N Y Acad Sci; 2002 Jun; 966():263-70. PubMed ID: 12114282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth hormone (GH)-releasing factor (GRF) pretreatment enhances the GRF-induced GH secretion in rats with the pituitary autotransplanted to the kidney capsule.
    Jansson JO; Carlsson L; Isaksson OG
    Endocrinology; 1985 Jan; 116(1):95-8. PubMed ID: 3917256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo and in vitro regulation of pituitary transcription factor-1 (Pit-1) by changes in the hormone environment.
    González-Parra S; Chowen JA; García-Segura LM; Argente J
    Neuroendocrinology; 1996 Jan; 63(1):3-15. PubMed ID: 8839350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential effects of insulin- and proinsulin-induced hypoglycemia on pituitary hormone and catecholamine secretion.
    Williams TC; Berelowitz M; Berk MA; Frohman LA
    Diabetes Care; 1987; 10(3):278-85. PubMed ID: 3109862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
    Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
    Losa M; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):467-73. PubMed ID: 3929513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modification of basal and GRF-stimulated cyclic AMP levels and growth hormone release by phospholipid metabolic enzyme inhibitors.
    Cronin MJ; MacLeod RM; Canonico PL
    Neuroendocrinology; 1985 Apr; 40(4):332-8. PubMed ID: 2986027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
    Okimura Y; Chihara K; Kita T; Kashio Y; Sato M; Kitajima N; Abe H; Takahashi K; Fujita T
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1074-9. PubMed ID: 3141449
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
    Denef C; Schramme C; Baes M
    Neuroendocrinology; 1985 Jan; 40(1):88-91. PubMed ID: 3918279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of cholinergic blockade on the growth hormone and prolactin response to insulin hypoglycaemia.
    Evans PJ; Dieguez C; Foord S; Peters JR; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):733-7. PubMed ID: 3893805
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytosolic protein kinase A mediates the growth hormone (GH)-releasing action of GH-releasing factor in purified rat somatotrophs.
    Wong AO; Moor BC; Hawkins CE; Narayanan N; Kraicer J
    Neuroendocrinology; 1995 May; 61(5):590-600. PubMed ID: 7617138
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.